Adeno-associated virus vectors can be efficiently produced without helper virus

被引:414
|
作者
Matsushita, T
Elliger, S
Elliger, C
Podsakoff, G
Villarreal, L
Kurtzman, GJ
Iwaki, Y
Colosi, P
机构
[1] Avigen Inc, Alameda, CA USA
[2] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA
[3] Univ So Calif, Sch Med, Dept Urol, Los Angeles, CA 90033 USA
关键词
AAV vector production; AAV helper genes; adenovirus;
D O I
10.1038/sj.gt.3300680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this work was to develop an efficient method for the production of adeno-associated virus (AAV) vectors in the absence of helper virus. The adenovirus regions that mediate AAV vector replication were identified and assembled into a helper plasmid. These included the VA, E2A and E4 regions. When this helper plasmid was cotransfected into 293 cells, along with plasmids encoding the AAV vector, and rep and cap genes, AAV vector was produced as efficiently as when using adenovirus infection as a source of help. CMV-driven constructs expressing the E4orf6 and the 72-M-r, E2A proteins were able to functionally replace the E4 and E2A regions, respectively. Therefore the minimum set of genes required to produce AAV helper activity equivalent to that provided by adenovirus infection consists of, or is a subset of, the following genes: the E4orf6 gene, the 72-M-r, E2A protein gene, the VA RNA genes and the E1 region. AAV vector preparations made with adenovirus and by the helper virus-free method were essentially indistinguishable with respect to particle density, particle to infectivity ratio, capsimer ratio and efficiency of muscle transduction in vivo. Only AAV vector preparations made by the helper virus-free method were not reactive with anti-adenovirus sera.
引用
收藏
页码:938 / 945
页数:8
相关论文
共 50 条
  • [41] Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus
    Leonard, Joshua N.
    Ferstl, Peter
    Delgado, Antonio
    Schaffer, David V.
    BIOTECHNOLOGY AND BIOENGINEERING, 2007, 97 (05) : 1170 - 1179
  • [42] Recombinant adeno-associated virus production evaluation in Chinese hamster ovary cells
    Cao, Thu M.
    Chen, Dayue
    Barnard, Gavin C.
    Shen, Amy
    BIOTECHNOLOGY AND BIOENGINEERING, 2024, 121 (01) : 395 - 402
  • [43] Diverse IgG Subclass Responses to Adeno-Associated Virus Infection and Vector Administration
    Murphy, Samuel L.
    Li, Hojun
    Mingozzi, Federico
    Sabatino, Denise E.
    Hui, Daniel J.
    Edmonson, Shyrie A.
    High, Katherine A.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (01) : 65 - 74
  • [44] The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo
    Xie, Yi-lin
    Wang, Ji-yao
    He, Yun
    Yu, Xiao-min
    Zheng, Qing-yun
    Ling, Chen
    Feng, Xi-lin
    Zhu, Li-qing
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2023, 21 (01): : 106 - 116
  • [45] Molecular Detection of Adeno-Associated Virus DNA in Cases of Spontaneous and Therapeutic Abortion
    Sayyadi-Dehno, Zahra
    Khorrami, Seyed Mahmood Seyed
    Ghavami, Nastaran
    Ghotbi-Zadeh, Fahimeh
    Khushideh, Maryam
    Hosseini, Mostafa
    Malekshahi, Somayeh Shatizadeh
    Shafiei-Jandaghi, Nazanin-Zahra
    FETAL AND PEDIATRIC PATHOLOGY, 2019, 38 (03) : 206 - 214
  • [46] Molecular characterization of novel Adeno-associated virus variants infecting human tissues
    Purohit, Nishtha
    Jain, Apurv
    Mathews, Vikram
    Jayandharan, Giridhara R.
    VIRUS RESEARCH, 2019, 272
  • [47] Cochlear gene transfer mediated by adeno-associated virus: Comparison of two surgical approaches
    Chien, Wade W.
    McDougald, Devin S.
    Roy, Soumen
    Fitzgerald, Tracy S.
    Cunningham, Lisa L.
    LARYNGOSCOPE, 2015, 125 (11) : 2557 - 2564
  • [48] Adeno-associated virus as a gene therapy vector: Vector development, production and clinical applications
    Grieger, JC
    Samulski, RJ
    GENE THERAPY AND GENE DELIVERY SYSTEMS, 2005, 99 : 119 - 145
  • [49] Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia
    Li, C.
    Narkbunnam, N.
    Samulski, R. J.
    Asokan, A.
    Hu, G.
    Jacobson, L. J.
    Manco-Johnson, M. J.
    Monahan, P. E.
    GENE THERAPY, 2012, 19 (03) : 288 - 294
  • [50] Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection
    Nambiar, Bindu
    Sookdeo, Cathleen Cornell
    Berthelette, Patricia
    Jackson, Robert
    Piraino, Susan
    Burnham, Brenda
    Nass, Shelley
    Souza, David
    O'Riordan, Catherine R.
    Vincent, Karen A.
    Cheng, Seng H.
    Armentano, Donna
    Kyostio-Moore, Sirkka
    HUMAN GENE THERAPY METHODS, 2017, 28 (01) : 23 - 38